BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12871990)

  • 1. Biochemical characterization and immunocytochemical localization of EM66, a novel peptide derived from secretogranin II, in the rat pituitary and adrenal glands.
    Montero-Hadjadje M; Pelletier G; Yon L; Li S; Guillemot J; Magoul R; Tillet Y; Vaudry H; Anouar Y
    J Histochem Cytochem; 2003 Aug; 51(8):1083-95. PubMed ID: 12871990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel secretogranin II-derived peptide (SgII(187-252)) in adult and fetal human adrenal glands using antibodies raised against the human recombinant peptide.
    Anouar Y; Desmoucelles C; Yon L; Leprince J; Breault L; Gallo-Payet N; Vaudry H
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2944-51. PubMed ID: 9709974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical characterisation and immunohistochemical localisation of the secretogranin II-derived peptide EM66 in the hypothalamus of the jerboa (Jaculus orientalis): modulation by food deprivation.
    Boutahricht M; Guillemot J; Montero-Hadjadje M; Bellafqih S; El Ouezzani S; Alaoui A; Yon L; Vaudry H; Anouar Y; Magoul R
    J Neuroendocrinol; 2005 Jun; 17(6):372-8. PubMed ID: 15929742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel secretogranin II-derived peptide in the adult and fetal human adrenal gland.
    Anouar Y; Yon L; Desmoucelles C; Leprince J; Breault L; Gallo-Payet N; Vaudry H
    Endocr Res; 1998; 24(3-4):731-6. PubMed ID: 9888568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of multiple signaling pathways in PACAP-induced EM66 secretion from chromaffin cells.
    Guillemot J; Aït-Ali D; Turquier V; Montero-Hadjadje M; Fournier A; Vaudry H; Anouar Y; Yon L
    Regul Pept; 2006 Nov; 137(1-2):79-88. PubMed ID: 16963134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the secretogranin II-derived peptide EM66 in pheochromocytomas as a potential marker for discriminating benign versus malignant tumors.
    Yon L; Guillemot J; Montero-Hadjadje M; Grumolato L; Leprince J; Lefebvre H; Contesse V; Plouin PF; Vaudry H; Anouar Y
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2579-85. PubMed ID: 12788858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical distribution of the secretogranin II-derived peptide EM66 in the rat hypothalamus: a comparative study with jerboa.
    Boutahricht M; Guillemot J; Montero-Hadjadje M; Barakat Y; El Ouezzani S; Alaoui A; Yon L; Vaudry H; Anouar Y; Magoul R
    Neurosci Lett; 2007 Mar; 414(3):268-72. PubMed ID: 17240057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression and processing of secretogranin II in relation to the status of pheochromocytoma: implications for the production of the tumoral marker EM66.
    Guillemot J; Thouënnon E; Guérin M; Vallet-Erdtmann V; Ravni A; Montéro-Hadjadje M; Lefebvre H; Klein M; Muresan M; Seidah NG; Anouar Y; Yon L
    J Mol Endocrinol; 2012 Apr; 48(2):115-27. PubMed ID: 22217803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromogranin A, chromogranin B and secretogranin II mRNAs in the pituitary and adrenal glands of various mammals. Regulation of chromogranin A, chromogranin B and secretogranin II mRNA levels by estrogen.
    Lloyd RV; Hawkins K; Jin L; Kulig E; Fields K
    Lab Invest; 1992 Sep; 67(3):394-404. PubMed ID: 1405495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of secretogranin-II (SgII) in the human fetal pituitary: immunocytochemical study using an antiserum raised against a human recombinant SgII.
    Vallet VS; Griffond B; Clavequin MC; de Monti M; Fellmann D; Duval J
    Endocrinology; 1995 May; 136(5):2074-81. PubMed ID: 7720657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization and characterization of evolutionarily conserved chromogranin A-derived peptides in the rat and human pituitary and adrenal glands.
    Montero-Hadjadje M; Vaudry H; Turquier V; Leprince J; Do Rego JL; Yon L; Gallo-Payet N; Plouin PF; Anouar Y
    Cell Tissue Res; 2002 Nov; 310(2):223-36. PubMed ID: 12397377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretogranin II: relative amounts and processing to secretoneurin in various rat tissues.
    Leitner B; Fischer-Colbrie R; Scherzer G; Winkler H
    J Neurochem; 1996 Mar; 66(3):1312-7. PubMed ID: 8769899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PACAP stimulates the release of the secretogranin II-derived peptide EM66 from chromaffin cells.
    Guillemot J; Ait-Ali D; Turquier V; Montero-Hadjadje M; Fournier A; Vaudry H; Anouar Y; Yon L
    Ann N Y Acad Sci; 2006 Jul; 1070():309-12. PubMed ID: 16888183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical distribution of EM66 within the hypothalamic parvocellular paraventricular nucleus: colocalization with CRH and TRH but no plasticity related to acute stress and thyroidectomy in the rat.
    El Yamani FZ; Yon L; Guérin M; El Ouezzani S; Alaoui A; Chartrel N; Anouar Y; Magoul R
    Regul Pept; 2013 Mar; 182():28-34. PubMed ID: 23333484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potential role for the secretogranin II-derived peptide EM66 in the hypothalamic regulation of feeding behaviour.
    Trebak F; Dubuc I; Arabo A; Alaoui A; Boukhzar L; Maucotel J; Picot M; Cherifi S; Duparc C; Leprince J; Prévost G; Anouar Y; Magoul R; Chartrel N
    J Neuroendocrinol; 2017 Mar; 29(3):. PubMed ID: 28166374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating EM66 is a highly sensitive marker for the diagnosis and follow-up of pheochromocytoma.
    Guillemot J; Anouar Y; Montero-Hadjadje M; Grouzmann E; Grumolato L; Roshmaninho-Salgado J; Turquier V; Duparc C; Lefebvre H; Plouin PF; Klein M; Muresan M; Chow BK; Vaudry H; Yon L
    Int J Cancer; 2006 Apr; 118(8):2003-12. PubMed ID: 16287097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manserin, a novel peptide from secretogranin II in the neuroendocrine system.
    Yajima A; Ikeda M; Miyazaki K; Maeshima T; Narita N; Narita M
    Neuroreport; 2004 Aug; 15(11):1755-9. PubMed ID: 15257142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretoneurin--a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C).
    Kirchmair R; Hogue-Angeletti R; Gutierrez J; Fischer-Colbrie R; Winkler H
    Neuroscience; 1993 Mar; 53(2):359-65. PubMed ID: 8492910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The secretogranin II-derived peptide secretoneurin stimulates luteinizing hormone secretion from gonadotrophs.
    Zhao E; Basak A; Wong AO; Ko W; Chen A; López GC; Grey CL; Canosa LF; Somoza GM; Chang JP; Trudeau VL
    Endocrinology; 2009 May; 150(5):2273-82. PubMed ID: 19106223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of secretoneurin, a novel neuropeptide endoproteolytically processed from secretogranin II, in normal human endocrine and neuronal tissues.
    Schmid KW; Kunk B; Kirchmair R; Tötsch M; Böcker W; Fischer-Colbrie R
    Histochem J; 1995 Jun; 27(6):473-81. PubMed ID: 7558897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.